Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Trimetazidine 60 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹259/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Trimetazidine 60 mg Tablet is a heart medicine used to prevent chest pain (angina) caused by reduced blood flow to the heart. It helps the heart use oxygen more efficiently, especially during physical activity or stress, which reduces the frequency of angina attacks. Unlike other heart medications, it does not change heart rate or blood pressure but improves the energy supply to heart muscle cells. The 60 mg strength is usually a sustained-release (SR) version, taken once or twice daily for long-lasting effect.
Common side effects include headache, dizziness, nausea, stomach discomfort, and fatigue. Rarely, it may cause tremors or movement problems, especially in elderly patients.
Helps to manage and prevent angina pectoris (chest pain) in people with coronary artery disease.
Take Trimetazidine 60 mg Tablet only as prescribed by your doctor. Do not use it to treat sudden chest pain; it is for prevention, not immediate relief. Inform your doctor if you have Parkinson’s disease, kidney problems, or any movement disorders. Report any unusual shaking or stiffness immediately. Continue the medication regularly for best results unless advised otherwise by your doctor.
Store in a cool, dry place below 30°C, protected from moisture and direct sunlight. Keep out of the reach of children.
Composition : Trimetazidine 20 mg tablet
Composition : Trimetazidine Hydrochloride I.P. 35mg Tablets
Composition : Diltiazem (90mg) Extend Release Capsule
Composition : Ranolazine 500 SR Tablet
Composition : Isosorbide 20 mg Tablet
Composition : Eplerenone 25 Mg Tablets
Composition : Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg) Tablet
Composition : Prazosin (2.5mg) Sustained Release Tablet
Composition : Sacubitril 49 mg + Valsartan 51 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Trimetazidine Controlled Release 60mg Tablet is a premium product in the cardiology and cardiovascular care segment. With the increasing prevalence of heart-related disorders and the growing demand for advanced cardiac therapies, this formulation enjoys strong prescription support from healthcare professionals. It offers excellent business opportunities for pharma franchise partners, distributors, stockists, and wholesalers looking to expand their cardiovascular product portfolio.
Medical distributors and pharma franchise companies can benefit from the consistent demand for specialized cardiovascular medications prescribed under medical supervision. Trimetazidine Controlled Release 60mg is an anti-anginal medication commonly used as part of the management of certain cardiovascular conditions under medical guidance The controlled-release formulation is designed to provide sustained drug release over an extended period Frequently prescribed by cardiologists and physicians as part of comprehensive cardiac care Widely utilized in long-term cardiovascular management plans Commonly available in hospitals, cardiac clinics, and retail pharmacy channels Maintains steady demand within the growing cardiology segment This product strengthens a comprehensive cardiology and cardiovascular care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Trimetazidine Controlled Release 60mg Tablet. Franchise partners receive monopoly rights, promotional support, attractive packaging, competitive pricing, and reliable supply chain assistance to help establish and grow their pharmaceutical business successfully.
Wholesalers, distributors, and medical agencies can benefit from: Strong prescription demand in the cardiology segment Regular repeat orders due to long-term treatment requirements Wide acceptance among cardiologists and physicians Attractive profit margins and business growth opportunities Reliable product availability and efficient logistics support Enhanced cardiovascular product portfolio with a specialized cardiac formulation
Interested distributors, wholesalers, stockists, and pharma professionals can partner with Cafoli LifeCare Pvt Ltd to market Trimetazidine Controlled Release 60mg Tablet across India. With exclusive monopoly-based franchise opportunities, comprehensive promotional support, quality-assured formulations, attractive business margins, competitive pricing, and dependable logistics assistance, Cafoli LifeCare Pvt Ltd helps partners establish and expand a successful pharmaceutical business.